From the report today:
- While the sales cycle for major scientific instruments is long (often awaiting award of research funding grants), Optiscan believes the market for the CellLIVETM will grow to some tens of units per year within the first several years.
- In November 2015, MRS placed their first order to Optiscan for “try before buy” seeding stock so as to convert the growing prospect pipeline.
No wonder why the board were not exited at the meeting. First several years - what the hell does that mean? ( not the first few years, but within several !! )
Sales look like they will be small and far between. Any idea on what the price per unit is. If less than $100g retail, taking out costs, profit will be shit.
Ann: Chairman's Address to Shareholders, page-19
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.020(9.30%) |
Mkt cap ! $162.8M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 18.0¢ | $331.5K | 1.677M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12665 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 17491 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| OIL (ASX) Chart |